19 results on '"Lerche, Holger"'
Search Results
2. Epilepsy-causing STX1B mutations translate altered protein functions into distinct phenotypes in mouse neurons.
- Author
-
Vardar, Gülçin, Gerth, Fabian, Schmitt, Xiao Jakob, Rautenstrauch, Pia, Trimbuch, Thorsten, Schubert, Julian, Lerche, Holger, Rosenmund, Christian, and Freund, Christian
- Subjects
NEURONS ,SYNAPTIC vesicles ,PROTEIN receptors ,PHENOTYPES ,SEIZURES (Medicine) ,NEUROCYSTICERCOSIS ,LENNOX-Gastaut syndrome ,NEURAL transmission ,RESEARCH ,GENETIC mutation ,EPILEPSY ,ANIMAL experimentation ,RESEARCH methodology ,EVALUATION research ,MEDICAL cooperation ,COMPARATIVE studies ,GENOTYPES ,MEMBRANE proteins ,MICE - Abstract
Syntaxin 1B (STX1B) is a core component of the N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex that is critical for the exocytosis of synaptic vesicles in the presynapse. SNARE-mediated vesicle fusion is assisted by Munc18-1, which recruits STX1B in the auto-inhibited conformation, while Munc13 catalyses the fast and efficient pairing of helices during SNARE complex formation. Mutations within the STX1B gene are associated with epilepsy. Here we analysed three STX1B mutations by biochemical and electrophysiological means. These three paradigmatic mutations cause epilepsy syndromes of different severity, from benign fever-associated seizures in childhood to severe epileptic encephalopathies. An insertion/deletion (K45/RMCIE, L46M) mutation (STX1BInDel), causing mild epilepsy and located in the early helical Habc domain, leads to an unfolded protein unable to sustain neurotransmission. STX1BG226R, causing epileptic encephalopathies, strongly compromises the interaction with Munc18-1 and reduces expression of both proteins, the size of the readily releasable pool of vesicles, and Ca2+-triggered neurotransmitter release when expressed in STX1-null neurons. The mutation STX1BV216E, also causing epileptic encephalopathies, only slightly diminishes Munc18-1 and Munc13 interactions, but leads to enhanced fusogenicity and increased vesicular release probability, also in STX1-null neurons. Even though the synaptic output remained unchanged in excitatory hippocampal STX1B+/- neurons exogenously expressing STX1B mutants, the manifestation of clear and distinct molecular disease mechanisms by these mutants suggest that certain forms of epilepsies can be conceptualized by assigning mutations to structurally sensitive regions of the STX1B-Munc18-1 interface, translating into distinct neurophysiological phenotypes. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
3. Expanding the phenotype of TRAK1 mutations: hyperekplexia and refractory status epilepticus.
- Author
-
Sagie, Shira, Lerman-Sagie, Tally, Maljevic, Snezana, Yosovich, Keren, Detert, Katja, Seo-Kyung Chung, Rees, Mark I., Lerche, Holger, Lev, Dorit, and Chung, Seo-Kyung
- Subjects
STATUS epilepticus ,GENETIC mutation ,PHENOTYPES ,GENETICS ,MEMBRANE proteins ,NEUROLOGICAL disorders ,STARTLE reaction - Published
- 2018
- Full Text
- View/download PDF
4. Synaptic or ion channel modifier? PRRT2 is a chameleon-like regulator of neuronal excitability.
- Author
-
Lerche, Holger
- Subjects
- *
ION channels , *GENETIC mutation , *DYSKINESIAS , *PATHOLOGICAL physiology , *MEMBRANE proteins , *SEIZURES (Medicine) , *SODIUM metabolism , *SPASMS , *GENE expression , *NEURAL transmission , *NEUROPLASTICITY , *SEQUENCE analysis , *GENETICS - Published
- 2018
- Full Text
- View/download PDF
5. Mutations in STX1B, encoding a presynaptic protein, cause fever-associated epilepsy syndromes.
- Author
-
Schubert, Julian, Becker, Felicitas, Weber, Yvonne G, Lerche, Holger, Thiele, Holger, Konrad, Kathryn, Kawalia, Amit, Toliat, Mohammad R, Sander, Thomas, Rüschendorf, Franz, Caliebe, Almuth, Nagel, Inga, Kohl, Bernard, Riesch, Erik, Dorn, Thomas, Baulac, Stephanie, Møller, Rikke S, Hjalgrim, Helle, Jurkat-Rott, Karin, and Lehman-Horn, Frank
- Subjects
PRESYNAPTIC receptors ,GENETICS of epilepsy ,DIAGNOSIS of epilepsy ,FEBRILE seizures ,SEIZURES in children ,GENETIC mutation - Abstract
Febrile seizures affect 2-4% of all children and have a strong genetic component. Recurrent mutations in three main genes (SCN1A, SCN1B and GABRG2) have been identified that cause febrile seizures with or without epilepsy. Here we report the identification of mutations in STX1B, encoding syntaxin-1B, that are associated with both febrile seizures and epilepsy. Whole-exome sequencing in independent large pedigrees identified cosegregating STX1B mutations predicted to cause an early truncation or an in-frame insertion or deletion. Three additional nonsense or missense mutations and a de novo microdeletion encompassing STX1B were then identified in 449 familial or sporadic cases. Video and local field potential analyses of zebrafish larvae with antisense knockdown of stx1b showed seizure-like behavior and epileptiform discharges that were highly sensitive to increased temperature. Wild-type human syntaxin-1B but not a mutated protein rescued the effects of stx1b knockdown in zebrafish. Our results thus implicate STX1B and the presynaptic release machinery in fever-associated epilepsy syndromes. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
6. Impaired Action Potential Initiation in GAB Aergic Interneurons Causes Hyperexcitable Networks in an Epileptic Mouse Model Carrying a Human NaV1.1 Mutation.
- Author
-
Hedrich, Ulrike B. S., Liautard, Camille, Kirschenbaum, Daniel, Pofahl, Martin, Lavigne, Jennifer, Yuanyuan Liu, Theiss, Stephan, Slotta, Johannes, Escayg, Andrew, Dihné, Marcel, Beck, Heinz, Mantegazza, Massimo, and Lerche, Holger
- Subjects
ACTION potentials ,GABA agents ,INTERNEURONS ,PEOPLE with epilepsy ,GENETIC mutation ,SODIUM ions ,LABORATORY mice - Abstract
Mutations in SCN1A and other ion channel genes can cause different epileptic phenotypes, but the precise mechanisms underlying the development of hyperexcitable networks are largely unknown. Here, we present a multisystem analysis of an SCN1A mouse model carrying the Na
v 1.1-R1648H mutation, which causes febrile seizures and epilepsy in humans. We found a ubiquitous hypoexcitability of interneurons in thalamus, cortex, and hippocampus, without detectable changes in excitatory neurons. Interestingly, somatic Na+ channels in interneurons and persistent Na+ currents were not significantly changed. Instead, the key mechanism of interneuron dysfunction was a deficit of action potential initiation at the axon initial segment that was identified by analyzing action potential firing. This deficit increased with the duration of firing periods, suggesting that increased slow inactivation, as recorded for recombinant mutated channels, could play an important role. The deficit in interneuron firing caused reduced action potential-driven inhibition of excitatory neurons as revealed by less frequent spontaneous but not miniature IPSCs. Multiple approaches indicated increased spontaneous thalamocortical and hippocampal network activity in mutant mice, as follows: (1) more synchronous and higher-frequency firing was recorded in primary neuronal cultures plated on multielectrode arrays; (2) thalamocortical slices examined by field potential recordings revealed spontaneous activities and pathological high-frequency oscillations; and (3) multineuron Ca2+ imaging in hippocampal slices showed increased spontaneous neuronal activity. Thus, an interneuron-specific generalized defect in action potential initiation causes multisystem disinhibition and network hyperexcitability, which can well explain the occurrence of seizures in the studied mouse model and in patients carrying this mutation. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
7. Reduced dendritic arborization and hyperexcitability of pyramidal neurons in a Scn1b-based model of Dravet syndrome.
- Author
-
Reid, Christopher A., Leaw, Bryan, Richards, Kay L., Richardson, Robert, Wimmer, Verena, Yu, Christiaan, Hill-Yardin, Elisa L., Lerche, Holger, Scheffer, Ingrid E., Berkovic, Samuel F., and Petrou, Steven
- Subjects
DENDRITIC cells ,PYRAMIDAL tract ,EPILEPSY ,GENETIC mutation ,SODIUM channels ,INTERNEURONS ,SEVERITY of illness index - Abstract
Dravet syndrome is an epileptic encephalopathy associated with mutations in the sodium channel subunits SCN1A or SCN1B. Although interneuron pathology is implicated in SCN1A-based Dravet syndrome, Reid et al. obtain evidence of excitatory neuron pathology in mice homozygous for the SCN1B mutation. This convergence of disease pathways may have therapeutic implications.Epileptic encephalopathies, including Dravet syndrome, are severe treatment-resistant epilepsies with developmental regression. We examined a mouse model based on a human β1 sodium channel subunit (Scn1b) mutation. Homozygous mutant mice shared phenotypic features and pharmaco-sensitivity with Dravet syndrome. Patch-clamp analysis showed that mutant subicular and layer 2/3 pyramidal neurons had increased action potential firing rates, presumably as a consequence of their increased input resistance. These changes were not seen in L5 or CA1 pyramidal neurons. This raised the concept of a regional seizure mechanism that was supported by data showing increased spontaneous synaptic activity in the subiculum but not CA1. Importantly, no changes in firing or synaptic properties of gamma-aminobutyric acidergic interneurons from mutant mice were observed, which is in contrast with Scn1a-based models of Dravet syndrome. Morphological analysis of subicular pyramidal neurons revealed reduced dendritic arborization. The antiepileptic drug retigabine, a K+ channel opener that reduces input resistance, dampened action potential firing and protected mutant mice from thermal seizures. These results suggest a novel mechanism of disease genesis in genetic epilepsy and demonstrate an effective mechanism-based treatment of the disease. [ABSTRACT FROM PUBLISHER]
- Published
- 2014
- Full Text
- View/download PDF
8. RBFOX1 and RBFOX3 Mutations in Rolandic Epilepsy.
- Author
-
Lal, Dennis, Reinthaler, Eva M., Altmüller, Janine, Toliat, Mohammad R., Thiele, Holger, Nürnberg, Peter, Lerche, Holger, Hahn, Andreas, Møller, Rikke S., Muhle, Hiltrud, Sander, Thomas, Zimprich, Fritz, and Neubauer, Bernd A.
- Subjects
TREATMENT of epilepsy ,DNA-binding proteins ,GENETIC mutation ,GENETIC engineering ,GENETIC code ,SINGLE nucleotide polymorphisms ,BIOLOGICAL assay - Abstract
Partial deletions of the gene encoding the neuronal splicing regulator RBFOX1 have been reported in a range of neurodevelopmental diseases, including idiopathic generalized epilepsy. The RBFOX1 protein and its homologues (RBFOX2 and RBFOX3) regulate alternative splicing of many neuronal transcripts involved in the homeostatic control of neuronal excitability. In this study, we explored if structural microdeletions and exonic sequence variations in RBFOX1, RBFOX2, RBFOX3 confer susceptibility to rolandic epilepsy (RE), a common idiopathic focal childhood epilepsy. By high-density SNP array screening of 289 unrelated RE patients, we identified two hemizygous deletions, a 365 kb deletion affecting two untranslated 5′-terminal exons of RBFOX1 and a 43 kb deletion spanning exon 3 of RBFOX3. Exome sequencing of 242 RE patients revealed two novel probably deleterious variants in RBFOX1, a frameshift mutation (p.A233Vfs*74) and a hexanucleotide deletion (p.A299_A300del), and a novel nonsense mutation in RBFOX3 (p.Y287*). Although the three variants were inherited from unaffected parents, they were present in all family members exhibiting the RE trait clinically or electroencephalographically with only one exception. In contrast, no deleterious mutations of RBFOX1 and RBFOX3 were found in the exomes of 6503 non-RE subjects deposited in the Exome Variant Server database. The observed RBFOX3 exon 3 deletion and nonsense mutation suggest that RBFOX3 represents a novel risk factor for RE, indicating that exon deletions and truncating mutations of RBFOX1 and RBFOX3 contribute to the genetic variance of partial and generalized idiopathic epilepsy syndromes. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
9. Ion channels in genetic and acquired forms of epilepsy.
- Author
-
Lerche, Holger, Shah, Mala, Beck, Heinz, Noebels, Jeff, Johnston, Dan, and VincENt, Angela
- Subjects
- *
GENETIC mutation , *GENETICS , *ION channels , *EPILEPSY , *POTASSIUM channels , *NEURONS - Abstract
Genetic mutations causing dysfunction of both voltage- and ligand-gated ion channels make a major contribution to the cause of many different types of familial epilepsy. Key mechanisms comprise defective Na+ channels of inhibitory neurons, or GABAA receptors affecting pre- or postsynaptic GABAergic inhibition, or a dysfunction of different types of channels at axon initial segments. Many of these ion channel mutations have been modelled in mice, which has largely contributed to the understanding of where and how the ion channel defects lead to neuronal hyperexcitability. Animal models of febrile seizures or mesial temporal epilepsy have shown that dendritic K+ channels, hyperpolarization-activated cation channels and T-type Ca2+ channels play important roles in the generation of seizures. For the latter, it has been shown that suppression of their function by pharmacological mechanisms or in knock-out mice can antagonize epileptogenesis. Defects of ion channel function are also associated with forms of acquired epilepsy. Autoantibodies directed against ion channels or associated proteins, such as K+ channels, LGI1 or NMDA receptors, have been identified in epileptic disorders that can largely be included under the term limbic encephalitis which includes limbic seizures, status epilepticus and psychiatric symptoms. We conclude that ion channels and associated proteins are important players in different types of genetic and acquired epilepsies. Nevertheless, the molecular bases for most common forms of epilepsy are not yet clear, and evidence to be discussed indicates just how much more we need to understand about the complex mechanisms that underlie epileptogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
10. Exon-disrupting deletions of NRXN1 in idiopathic generalized epilepsy.
- Author
-
Møller, Rikke S., Weber, Yvonne G., Klitten, Laura L., Trucks, Holger, Muhle, Hiltrud, Kunz, Wolfram S., Mefford, Heather C., Franke, Andre, Kautza, Monika, Wolf, Peter, Dennig, Dieter, Schreiber, Stefan, Rückert, Ina‐Maria, Wichmann, H.‐Erich, Ernst, Jan P., Schurmann, Claudia, Grabe, Hans J., Tommerup, Niels, Stephani, Ulrich, and Lerche, Holger
- Subjects
EXONS (Genetics) ,EPILEPSY ,NEUREXINS ,CELL adhesion molecules ,PRESYNAPTIC receptors ,NEURAL transmission ,GENETIC mutation - Abstract
Purpose Neurexins are neuronal adhesion molecules located in the presynaptic terminal, where they interact with postsynaptic neuroligins to form a transsynaptic complex required for efficient neurotransmission in the brain. Recently, deletions and point mutations of the neurexin 1 ( NRXN1) gene have been associated with a broad spectrum of neuropsychiatric disorders. This study aimed to investigate if NRXN1 deletions also increase the risk of idiopathic generalized epilepsies ( IGEs). Methods We screened for deletions involving the NRXN1 gene in 1,569 patients with IGE and 6,201 controls using high-density oligonucleotide microarrays. Key Findings We identified exon-disrupting deletions of NRXN1 in 5 of 1,569 patients with IGE and 2 of 6,201 control individuals (p = 0.0049; odds ratio ( OR) 9.91, 95% confidence interval ( CI) 1.92-51.12). A complex familial segregation pattern in the IGE families was observed, suggesting that heterozygous NRXN1 deletions are susceptibility variants. Intriguingly, we identified a second large copy number variant in three of five index patients, supporting an involvement of heterogeneous susceptibility alleles in the etiology of IGE. Significance We conclude that exon-disrupting deletions of NRXN1 represent a genetic risk factor in the genetically complex predisposition of common IGE syndromes. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
11. Genetic mechanisms in idiopathic epilepsies.
- Author
-
Weber, Yvonne G. and Lerche, Holger
- Subjects
- *
GENETICS of epilepsy , *DEVELOPMENTAL disabilities , *GENETIC mutation , *GENETICS , *DRUG therapy - Abstract
Idiopathic epilepsies are considered to be genetically determined. The inheritance can be monogenic and the detected mutation considered sufficient to cause the phenotype. In contrast, when the inheritance is complex, the epileptic phenotype is determined by several minor genetic defects that are much more difficult to discover. In recent years, an increasing number of mutations, mainly associated with rare monogenic idiopathic epilepsy syndromes, have been identified in genes encoding subunits of voltage- or ligand-gated ion channels. A few mutations have also been found in the frequent classical forms of idiopathic generalized epilepsies which are thought to follow a complex genetic trait, for example, in absence or juvenile myoclonic epilepsies. Functional studies characterizing the molecular defects of the mutant channels point to an important role of GABAergic synaptic inhibition in the pathophysiology of idiopathic epilepsies. As a result of genetic and functional investigations, not only will the pathophysiology of epilepsy be better understood, but newly discovered genes and pathophysiological pathways may also determine novel targets for pharmacotherapy, as has been shown for the anticonvulsant drug retigabine, which enhances the activity of neuronal KCNQ potassium channels. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
12. Molecular analysis of the A322D mutation in the GABAA receptor α1-subunit causing juvenile myoclonic epilepsy.
- Author
-
Krampfl, Klaus, Maljevic, Snezana, Cossette, Patrick, Ziegler, Elke, Rouleau, Guy A., Lerche, Holger, and Bufler, Johannes
- Subjects
GENETIC mutation ,CHILDHOOD epilepsy ,INTELLECTUAL disabilities ,GENETIC disorders ,GREEN fluorescent protein ,FLUORESCENT polymers - Abstract
Juvenile myoclonic epilepsy (JME) belongs to the most common forms of hereditary epilepsy, the idiopathic generalized epilepsies. Although the mode of inheritance is usually complex, mutations in single genes have been shown to cause the disease in some families with autosomal dominant inheritance. The first mutation in a multigeneration JME family has been recently found in the α
1 -subunit of the GABAA receptor ( GABRA1), predicting the single amino acid substitution A322D. We further characterized the functional consequences of this mutation by coexpressing α1 -, β2 - and γ2 -subunits in human embryonic kidney (HEK293) cells. By using an ultrafast application system, mutant receptors have shown reduced macroscopic current amplitudes at saturating GABA concentrations and a highly reduced affinity to GABA compared to the wild-type (WT). Dose–response curves for current amplitudes, activation kinetics, and GABA-dependent desensitization parameters showed a parallel shift towards 30- to 40-fold higher GABA concentrations. Both deactivation and resensitization kinetics were considerably accelerated in mutant channels. In addition, mutant receptors labelled with enhanced green fluorescent protein (EGFP) were not integrated in the cell membrane, in contrast to WT receptors. Therefore, the A322D mutation leads to a severe loss-of-function of the human GABAA receptor by several mechanisms, including reduced surface expression, reduced GABA-sensitivity, and accelerated deactivation. These molecular defects could decrease and shorten the resulting inhibitory postsynaptic currents (IPSCs) in vivo, which can induce a hyperexcitability of the postsynaptic membrane and explain the occurrence of epileptic seizures. [ABSTRACT FROM AUTHOR]- Published
- 2005
- Full Text
- View/download PDF
13. Letter to the editor: confirming neonatal seizure and late onset ataxia in SCN2A Ala263Val.
- Author
-
Johannesen, Katrine, Miranda, Maria, Lerche, Holger, and Møller, Rikke
- Subjects
GENETIC mutation ,CHILDHOOD epilepsy ,ATAXIA - Abstract
A letter to the editor is presented in response to the article "Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia," by N. Schwarz and colleagues in the February 2016 issue.
- Published
- 2016
- Full Text
- View/download PDF
14. Homozygous mutation in TXNRD1 is associated with genetic generalized epilepsy.
- Author
-
Kudin, Alexei P., Baron, Gregor, Zsurka, Gábor, Hampel, Kevin G., Elger, Christian E., Grote, Alexander, Weber, Yvonne, Lerche, Holger, Thiele, Holger, Nürnberg, Peter, Schulz, Herbert, Ruppert, Ann-Kathrin, Sander, Thomas, Cheng, Qing, Arnér, Elias SJ, Schomburg, Lutz, Seeher, Sandra, Fradejas-Villar, Noelia, Schweizer, Ulrich, and Kunz, Wolfram S.
- Subjects
- *
GENETICS of epilepsy , *GENETIC mutation , *HOMOZYGOSITY , *OXIDATIVE stress , *THIOREDOXIN reductase (NADPH) - Abstract
Increased oxidative stress has been widely implicated in the pathogenesis in various forms of human epilepsy. Here, we report a homozygous mutation in TXNRD1 (thioredoxin reductase 1) in a family with genetic generalized epilepsy. TXNRD1 is an essential selenium-containing enzyme involved in detoxification of reactive oxygen species (ROS) and redox signaling. The TXNRD1 mutation p.Pro190Leu affecting a highly conserved amino acid residue was identified by whole-exome sequencing of blood DNA from the index patient. The detected mutation and its segregation within the family – all siblings of the index patient were homozygous and the parents heterozygous – were confirmed by Sanger sequencing. TXNRD1 activity was determined in subcellular fractions from a skeletal muscle biopsy and skin fibroblasts of the index patient and the expression levels of the mutated protein were assessed by 75 Se labeling and Western blot analysis. As result of the mutation, the activity of TXNRD1 was reduced in the patient's fibroblasts and skeletal muscle (to 34±3% and 16±8% of controls, respectively). In fibroblasts, we detected reduced 75 Se-labeling of the enzyme (41±3% of controls). An in-depth in vitro kinetic analysis of the recombinant mutated TXNRD1 indicated 30–40% lowered k cat /Se values. Therefore, a reduced activity of the enzyme in the patient's tissue samples is explained by (i) lower enzyme turnover and (ii) reduced abundance of the mutated enzyme as confirmed by Western blotting and 75 Se labeling. The mutant fibroblasts were also found to be less resistant to a hydrogen peroxide challenge. Our data agree with a potential role of insufficient ROS detoxification for disease manifestation in genetic generalized epilepsy. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
15. Early-onset familial hemiplegic migraine due to a novel SCN1A mutation.
- Author
-
Fan, Chunxiang, Wolking, Stefan, Lehmann-Horn, Frank, Hedrich, Ulrike B. S., Freilinger, Tobias, Lerche, Holger, Borck, Guntram, Kubisch, Christian, Jurkat-Rott, Karin, and Hedrich, Ulrike Bs
- Subjects
- *
MIGRAINE , *GENETIC mutation , *GENETIC testing , *INTERNEURONS , *ELECTROPHYSIOLOGY , *GENETICS , *MIGRAINE diagnosis , *DISEASE susceptibility , *GENEALOGY , *GENETIC polymorphisms , *GENETIC techniques , *GENETIC markers , *MEMBRANE transport proteins - Abstract
Introduction Familial hemiplegic migraine (FHM) is a rare autosomal dominant subtype of migraine with aura. The FHM3 subtype is caused by mutations in SCN1A, which is also the most frequent epilepsy gene encoding the voltage-gated Na+ channel NaV1.1. The aim of this study was to explore the clinical, genetic and pathogenetic features of a pure FHM3 family. Methods A three-generation family was enrolled in this study for genetic testing and assessment of clinical features. Whole cell patch-clamp was performed to determine the functions of identified mutant NaV1.1 channels, which were transiently expressed in human tsA201 cells together with β1 and β2 subunits. Results and conclusions We identified a novel SCN1A (p.Leu1624Pro) mutation in a pure FHM family with notably early-onset attacks at mean age of 7. L1624P locates in S3 of domain IV, the same domain as two of four known pure FHM3 mutations. Compared to WT channels, L1624P displayed an increased threshold-near persistent current in addition to other gain-of-function features such as: a slowing of fast inactivation, a positive shift in steady-state inactivation, a faster recovery and higher channel availability during repetitive stimulation. Similar to the known FHM3 mutations, this novel mutation predicts hyperexcitability of GABAergic inhibitory neurons. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
16. Investigation of GRIN2A in common epilepsy phenotypes.
- Author
-
Lal, Dennis, Steinbrücker, Sandra, Schubert, Julian, Sander, Thomas, Becker, Felicitas, Weber, Yvonne, Lerche, Holger, Thiele, Holger, Krause, Roland, Lehesjoki, Anna-Elina, Nürnberg, Peter, Palotie, Aarno, Neubauer, Bernd A., Muhle, Hiltrud, Stephani, Ulrich, Helbig, Ingo, Becker, Albert J., Schoch, Susanne, Hansen, Jörg, and Dorn, Thomas
- Subjects
- *
GLUTAMATE receptors , *GENETICS of epilepsy , *HUMAN phenotype , *TREATMENT of epilepsy , *GENETIC mutation , *TEMPORAL lobe epilepsy , *DELETION mutation , *THERAPEUTICS - Abstract
Recently, mutations and deletions in the GRIN2A gene have been identified to predispose to benign and severe idiopathic focal epilepsies (IFE), revealing a higher incidence of GRIN2A alterations among the more severe phenotypes. This study aimed to explore the phenotypic boundaries of GRIN2A mutations by investigating patients with the two most common epilepsy syndromes: (i) idiopathic generalized epilepsy (IGE) and (ii) temporal lobe epilepsy (TLE). Whole exome sequencing data of 238 patients with IGE as well as Sanger sequencing of 84 patients with TLE were evaluated for GRIN2A sequence alterations. Two additional independent cohorts comprising 1469 IGE and 330 TLE patients were screened for structural deletions (>40 kb) involving GRIN2A . Apart from a presumably benign, non-segregating variant in a patient with juvenile absence epilepsy, neither mutations nor deletions were detected in either cohort. These findings suggest that mutations in GRIN2A preferentially are involved in genetic variance of pediatric IFE and do not contribute significantly to either adult focal epilepsies as TLE or generalized epilepsies. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
17. Axon initial segment dysfunction in a mouse model of genetic epilepsy with febrile seizures plus.
- Author
-
Wimmer, Verena C., Reid, Christopher A., Mitchell, Suzanne, Richards, Kay L., Scaf, Byron B., Leaw, Bryan T., Hill, Elisa L., Royeck, Michel, Horstmann, Marie-Therese, Cromer, Brett A., Davies, Philip J., Ruwei Xu, Lerche, Holger, Berkovic, Samuel F., Beck, Heinz, Petrou, Steven, and Xu, Ruwei
- Subjects
- *
FEBRILE seizures , *EPILEPSY , *HIPPOCAMPUS (Brain) , *GENETIC mutation , *NEURONS - Abstract
Febrile seizures are a common childhood seizure disorder and a defining feature of genetic epilepsy with febrile seizures plus (GEFS+), a syndrome frequently associated with Na+ channel mutations. Here, we describe the creation of a knockin mouse heterozygous for the C121W mutation of the beta1 Na+ channel accessory subunit seen in patients with GEFS+. Heterozygous mice with increased core temperature displayed behavioral arrest and were more susceptible to thermal challenge than wild-type mice. Wild-type beta1 was most concentrated in the membrane of axon initial segments (AIS) of pyramidal neurons, while the beta1(C121W) mutant subunit was excluded from AIS membranes. In addition, AIS function, an indicator of neuronal excitability, was substantially enhanced in hippocampal pyramidal neurons of the heterozygous mouse specifically at higher temperatures. Computational modeling predicted that this enhanced excitability was caused by hyperpolarized voltage activation of AIS Na+ channels. This heat-sensitive increased neuronal excitability presumably contributed to the heightened thermal seizure susceptibility and epileptiform discharges seen in patients and mice with beta1(C121W) subunits. We therefore conclude that Na+ channel beta1 subunits modulate AIS excitability and that epilepsy can arise if this modulation is impaired. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
18. Immunohistochemical analysis of KCNQ3 potassium channels in mouse brain
- Author
-
Geiger, Julia, Weber, Yvonne G., Landwehrmeyer, Bernhard, Sommer, Clemens, and Lerche, Holger
- Subjects
- *
NERVOUS system , *POTASSIUM channels , *GENOTYPE-environment interaction , *GENETIC mutation - Abstract
Abstract: KCNQ-type potassium channels generate the so-called M-current regulating excitability in many neurons. Mutations in KCNQ2/KCNQ3 channels can cause benign familial neonatal convulsions (BFNC). We describe the immunohistochemical staining of adult and developing mouse brain using an antibody directed against the N-terminus of KCNQ3 channels (KCNQ3N). A widespread KCNQ3N immunoreactivity predominantly of neuropil but also of somata was detected in different regions of the adult mouse brain, in particular in the hippocampus, cortex, thalamus and cerebellum. This staining pattern appeared gradually and became more intense during development. In the pyramidal cell layer of the hippocampus, the immunoreactivity changed from a more somatic to a neuropil staining during development. These changes during maturation might be related to the age-dependent phenotype of BFNC. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
19. Possible Effect of Corticoids on Hemiplegic Attacks in Severe Hemiplegic Migraine.
- Author
-
Sánchez-Albisua, Iciar, Schöning, Martin, Jurkat-Rott, Karin, and Lerche, Holger
- Subjects
- *
ADRENOCORTICAL hormones , *HEMIPLEGICS , *HEADACHE treatment , *MIGRAINE , *RARE diseases , *HEADACHE , *GENETIC mutation , *METHYLPREDNISOLONE - Abstract
Abstract: Background: Sporadic and familial hemiplegic migraines are rare paroxysmal disorders characterized by transient hemiparesis and headache. The distinction is based on whether other family members are affected. In 50% of cases, these migraines are caused by CACNA1 A missense mutations. Patients: We describe a boy with a particularly severe phenotype and a de novo R1349Q mutation of the CACNA1 A gene. Results: The patient suffered from early-onset profound mental retardation, epileptic seizures, cerebellar ataxia, and progressive cerebellar atrophy. He experienced prolonged attacks of migraine with hemiparesis, seizures, altered consciousness, and fever resulting from minor head traumas. A prolonged hemiplegic attack improved following a 5-day treatment of 100 mg/d methylprednisolone. Conclusion: R1349Q mutation of the CACN1 A gene may be associated with a severe phenotype. Corticoids might be beneficial in prolonged hemiplegic attacks. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.